Nivolumab vs Vancomycin

## Nivolumab vs Vancomycin: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Vancomycin**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Vancomycin**: Glycopeptide antibiotic inhibiting cell wall synthesis by binding D-Ala-D-Ala terminus of peptidoglycan precursors.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Vancomycin — 4-6 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Vancomycin — C66H75Cl2N9O24.

**Molecular Weight**: Nivolumab — N/A; Vancomycin — 1449.2500 g/mol.

**Type**: Nivolumab — Antibody; Vancomycin — Small molecule.